Navigation Links
OncoSec Medical Reports Positive Preliminary Efficacy Results from Phase II Study of ImmunoPulse in Metastatic Melanoma Patients
Date:11/15/2012

SAN DIEGO, Nov. 15, 2012 /PRNewswire/ -- OncoSec Medical Inc. (OTCBB: ONCS), a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy to treat solid tumors, announces positive preliminary results from a Phase II trial investigating the use of ImmunoPulse in metastatic melanoma patients at the 6th World Meeting of Interdisciplinary Melanoma Skin Cancer Centres & 8th EADO Congress. This preliminary interim analysis of 13 out of 25 patients supports key findings from a Phase I trial suggesting that ImmunoPulse is able to induce regression or stabilization of distant untreated metastases following a single cycle of treatment.

(Logo:  http://photos.prnewswire.com/prnh/20120905/LA68078LOGO)   

A total of up to 25 patients with stage III or IV cutaneous and in-transit metastatic melanoma will be enrolled in this Phase II, single-arm, open-label and multi-center study. The trial was designed to assess local and distant objective response following treatment of cutaneous melanoma lesions with ImmunoPulse. As per the protocol, a preliminary interim analysis was scheduled upon completion of 50 percent enrollment in the study.

The purpose of the analysis was to confirm safety and efficacy observed in the Phase I study. At the time of this preliminary interim analysis, 13 patients were enrolled and treated. Thirteen subjects were evaluable at Day 39, nine at Day 90, and two at Day 180. Ninety-five percent of treated lesions demonstrated response at Day 39 (5 percent progressive disease, 14 percent stable disease (SD), 42 percent partial response (PR), 39 percent complete response (CR)). All treated lesions at Day 90 (5 percent SD, 50 percent PR, 45 percent CR), and at Day 180 (33 percent PR, 67 percent CR) demonstrated a response. At Day 180, two subjects were evaluable for the primary endpoint of objective overall respons
'/>"/>

SOURCE OncoSec Medical Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. OncoSec Medical Reports Positive Interim Efficacy Results from Phase IV Study of NeoPulse in Skin Cancer Patients
2. OncoSec to Present at Upcoming Healthcare and Investor Conferences
3. OncoSec Granted New Patent from China
4. OncoSec to Present at the Rodman & Renshaw 2012 Annual Global Investment Conference
5. OncoSec Featured on KTVU-TV News and in San Francisco Chronicle
6. OncoSec OMS ElectroChemotherapy for Head and Neck Cancer Shows Enhanced Quality of Life in Two Randomized Phase III Studies
7. OncoSec Establishes Clinical Site for Its Phase II Merkel Cell Carcinoma Trial at University of California San Francisco (UCSF)
8. OncoSec Presents Preliminary Safety Data for Phase II Melanoma Study at Second European Post-Chicago Melanoma Meeting 2012
9. OncoSec Medical Issues Letter to Shareholders
10. OncoSec ElectroChemotherapy Demonstrates Potential as Alternative to Surgery for Treating Head and Neck Cancer
11. Patient and Disability Groups Support Bill to Begin Market Pricing System for Home Medical Equipment in Medicare
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... SHENZHEN , Chine, 3 juillet 2015 ... séquençage à haut débit de l,ADN situé à ... la certification de  l,American College of Pathologists  (Collège ... BGI à Hong Kong ... nouvelle génération à recevoir la certification du CAP ...
(Date:7/2/2015)... July 2, 2015  Fort Lauderdale-based investment banking ... announce that its Consumer Group completed the sale ... Group plc (ISE: KRZ) ("Kerry"), one of the ... systems, as well as functional ingredients and actives ... Farlie Turner served as the exclusive financial advisor ...
(Date:7/2/2015)... Research and Markets( http://www.researchandmarkets.com/research/n7kzjb/vitamin_d_market ) has announced the ... End-User & by Region - Global Trends & Forecast to ... is projected to reach about $2.5 Million by 2020, with ... opportunities in countries such as India , ... and Brazil . In 2013, the North ...
Breaking Medicine Technology:BGI obtient la certification du Collège des pathologistes américains (CAP) 2Farlie Turner's Consumer Group Completes Sale of Insight Beverages to Kerry 2Vitamin D Market by Analog, Application, End-User & by Region - Global Trends & Forecast to 2020: Increasing Recommendation By Doctors & Associations 2Vitamin D Market by Analog, Application, End-User & by Region - Global Trends & Forecast to 2020: Increasing Recommendation By Doctors & Associations 3
... -- ECLINSO AG, a leading provider of ... announced today that it has entered into a strategic ... eClinical technology solutions company, offering its CDISC-certified Electronic Data ... related tools such as the STUDY COMPOSER and the ...
... Mylan Inc. (Nasdaq: MYL ) today commented ... infringement lawsuit against Sunovion Pharmaceuticals Inc. in relation to Sunovion,s ... Southern District of New York granted Sunovion,s motion regarding one ... Mylan is disappointed in today,s ruling and believes the Court ...
Cached Medicine Technology:ECLINSO Announces Partnership with XClinical 2ECLINSO Announces Partnership with XClinical 3
(Date:7/2/2015)... VA (PRWEB) , ... July 02, 2015 , ... sweetFrog ... Texas. The opening is now the 19th sweetFrog store located in the Lone Star ... list of fastest growing companies in 2014. , The store, which opened July 1 ...
(Date:7/2/2015)... ... July 02, 2015 , ... When Walker Parking Consultants ... University of Minnesota, they knew it would save the university energy and maintenance ... choice: the total energy savings after installation was an impressive 89 percent, which ...
(Date:7/2/2015)... ... ... 2012, Patrick Achebe realized that the gift of poetry was fully in him, as beautiful ... poem, and three years later he was publishing an entire book of poetry. He knew ... "I have always believed that the best way to lift yourself up, is in the ...
(Date:7/2/2015)... ... 02, 2015 , ... Get ready to hit the gym, ... the socks were first introduced, they have rapidly been gaining attention among active ... new, fun shades including: blue, lime, pink and red. , Utilizing innovative ...
(Date:7/2/2015)... ... July 02, 2015 , ... The ZAC Foundation, a national leader ... with important lessons on how to stay water safe with the help of a ... authored by The ZAC Foundation co-founders, follows Zeke’s water safety journey. Zeke, who ...
Breaking Medicine News(10 mins):Health News:sweetFrog Expands Texas Footprint with Location in Canton 2Health News:Kenall’s TekDek™ Helps University Achieve Award-Winning Energy Savings in Parking Structure Lighting Retrofit 2Health News:Patrick Achebe Releases Debut Book, Whispering Waves: Poems for Everyday Grace 2Health News:SIGVARIS is Sporting Four Brand New Colors in the Popular PERFORMANCE SOCK Product Line 2Health News:The ZAC Foundation Kicks Off Summer and July 4th Weekend with Complimentary Children’s E-Book on Water Safety 2Health News:The ZAC Foundation Kicks Off Summer and July 4th Weekend with Complimentary Children’s E-Book on Water Safety 3
... Millennium ... Research Group, WALTHAM, Mass., Oct. 14 ... 2009 report, the,US market for ventral hernia repair is valued at almost ... next five years. This market,comprises both synthetic mesh and biologic mesh materials, ...
... Sales of $15.9 Billion Increased 6.4% Versus a Year ... 2008 Third-Quarter EPS Increased 10.4%*, NEW BRUNSWICK, N.J., ... $15.9 billion for the third quarter of,2008, an increase ... 2007.,Operational growth was 3.3% and the positive impact of ...
... (Amex: ETC ) ("ETC" or the "Company") ... three new contracts. The,contracts include a new Portable ... systems from separate life science research,organizations., The ... order from an,existing customer. The two bulk-sized sterilization ...
... new PROMUS(TM) ... accounts, NATICK, ... estimated U.S. market shares for,September for its two drug-eluting stents (DES), based ... to the healthcare sector., Based on the MRG data, the Company ...
... GIA Group, a global leader in customized Market Intelligence and Strategic ... China, Hong Kong, Singapore, Germany and Netherlands, giving the group 10 ... analysis and industry verticals. , ... Helsinki (PRWEB) October ...
... Principal Shareholder Shows Continuing Commitment by Financing All Cash Transaction ... ... Enterprise PACS, NEW YORK and BIRMINGHAM, Ala., Oct. 13 ... EMAG ) today announced the signing of a definitive agreement ...
Cached Medicine News:Health News:Ventral Hernia Repair Market to Grow to Over $800 Million in 2013 2Health News:Johnson & Johnson Reports 2008 Third-Quarter Results: 2Health News:Johnson & Johnson Reports 2008 Third-Quarter Results: 3Health News:Johnson & Johnson Reports 2008 Third-Quarter Results: 4Health News:Johnson & Johnson Reports 2008 Third-Quarter Results: 5Health News:Johnson & Johnson Reports 2008 Third-Quarter Results: 6Health News:Johnson & Johnson Reports 2008 Third-Quarter Results: 7Health News:Johnson & Johnson Reports 2008 Third-Quarter Results: 8Health News:Johnson & Johnson Reports 2008 Third-Quarter Results: 9Health News:Johnson & Johnson Reports 2008 Third-Quarter Results: 10Health News:Johnson & Johnson Reports 2008 Third-Quarter Results: 11Health News:Johnson & Johnson Reports 2008 Third-Quarter Results: 12Health News:Johnson & Johnson Reports 2008 Third-Quarter Results: 13Health News:Johnson & Johnson Reports 2008 Third-Quarter Results: 14Health News:Johnson & Johnson Reports 2008 Third-Quarter Results: 15Health News:Johnson & Johnson Reports 2008 Third-Quarter Results: 16Health News:Johnson & Johnson Reports 2008 Third-Quarter Results: 17Health News:Johnson & Johnson Reports 2008 Third-Quarter Results: 18Health News:Johnson & Johnson Reports 2008 Third-Quarter Results: 19Health News:Johnson & Johnson Reports 2008 Third-Quarter Results: 20Health News:Johnson & Johnson Reports 2008 Third-Quarter Results: 21Health News:Environmental Tectonics Corporation's Sterilization Systems Group Announces the Receipt of Three New Contracts 2Health News:Environmental Tectonics Corporation's Sterilization Systems Group Announces the Receipt of Three New Contracts 3Health News:Boston Scientific Announces Drug-Eluting Stent Market Share Estimates for September and Third Quarter 2Health News:Boston Scientific Announces Drug-Eluting Stent Market Share Estimates for September and Third Quarter 3Health News:Boston Scientific Announces Drug-Eluting Stent Market Share Estimates for September and Third Quarter 4Health News:Global Intelligence Alliance Strengthens Group Organization and Adds Local Presence, Merges With Asian, German and Dutch Partner Companies 2Health News:Health Systems Solutions Enters into Agreement to Acquire Emageon to Create Healthcare Technology Leader 2Health News:Health Systems Solutions Enters into Agreement to Acquire Emageon to Create Healthcare Technology Leader 3Health News:Health Systems Solutions Enters into Agreement to Acquire Emageon to Create Healthcare Technology Leader 4Health News:Health Systems Solutions Enters into Agreement to Acquire Emageon to Create Healthcare Technology Leader 5Health News:Health Systems Solutions Enters into Agreement to Acquire Emageon to Create Healthcare Technology Leader 6
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: